JPS635020A - 制御放出性イブプロフエン製剤 - Google Patents

制御放出性イブプロフエン製剤

Info

Publication number
JPS635020A
JPS635020A JP61303589A JP30358986A JPS635020A JP S635020 A JPS635020 A JP S635020A JP 61303589 A JP61303589 A JP 61303589A JP 30358986 A JP30358986 A JP 30358986A JP S635020 A JPS635020 A JP S635020A
Authority
JP
Japan
Prior art keywords
ibuprofen
microspheres
mixture
cellulose
binder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP61303589A
Other languages
English (en)
Japanese (ja)
Inventor
プヤレ　ラル　セス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MEFUA AG
Original Assignee
MEFUA AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MEFUA AG filed Critical MEFUA AG
Publication of JPS635020A publication Critical patent/JPS635020A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Control Of El Displays (AREA)
  • Manufacturing Of Tubular Articles Or Embedded Moulded Articles (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
JP61303589A 1986-06-25 1986-12-19 制御放出性イブプロフエン製剤 Pending JPS635020A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH02553/86-0 1986-06-25
CH2553/86A CH669523A5 (en, 2012) 1986-06-25 1986-06-25

Publications (1)

Publication Number Publication Date
JPS635020A true JPS635020A (ja) 1988-01-11

Family

ID=4236387

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61303589A Pending JPS635020A (ja) 1986-06-25 1986-12-19 制御放出性イブプロフエン製剤

Country Status (18)

Country Link
US (1) US4867987A (en, 2012)
EP (1) EP0250648B1 (en, 2012)
JP (1) JPS635020A (en, 2012)
KR (1) KR930008956B1 (en, 2012)
CN (1) CN1023191C (en, 2012)
AT (1) ATE66370T1 (en, 2012)
AU (1) AU590370B2 (en, 2012)
CA (1) CA1276560C (en, 2012)
CH (1) CH669523A5 (en, 2012)
DE (1) DE3681031D1 (en, 2012)
DK (1) DK616186A (en, 2012)
ES (1) ES2029228T3 (en, 2012)
FI (1) FI88580C (en, 2012)
GR (1) GR3002579T3 (en, 2012)
IL (1) IL81045A (en, 2012)
NO (1) NO173081C (en, 2012)
NZ (1) NZ218734A (en, 2012)
ZA (1) ZA869586B (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011132219A (ja) * 2009-11-24 2011-07-07 Taisho Pharmaceutical Co Ltd イブプロフェン含有固形製剤

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
US4970081A (en) * 1989-01-03 1990-11-13 Sterling Drug Inc. Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
US5213807A (en) * 1990-05-03 1993-05-25 Chemburkar Pramod B Pharmaceutical composition containing ibuprofen and a prostaglandin
JPH04230625A (ja) * 1990-12-27 1992-08-19 Standard Chem & Pharmaceut Corp Ltd 噴霧乾燥したジクロフェナクナトリウムを含み腸溶性の被覆を有するマイクロカプセルからなる微分散した錠剤組成物の製造方法
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
AU2002217647A1 (en) * 2000-11-28 2002-06-11 Irina Alekseevna Komissarova Pharmaceutical composition, the use thereof and method for producing said composition
WO2004026283A1 (en) 2002-09-20 2004-04-01 Alpharma, Inc. Sequestering subunit and related compositions and metohds
CN101115409B (zh) * 2005-02-04 2013-03-27 菲利普莫里斯生产公司 具有纤维质滋味添加剂的香烟及过滤嘴
DE102005037630A1 (de) 2005-08-09 2007-02-15 Glatt Gmbh Verfahren zur Herstellung von Teilchen aus pharmazeutischen Substanzen, Teilchen aus pharmazeutischen Substanzen sowie deren Verwendung
CA2633266C (en) * 2005-12-16 2011-08-02 Hanmi Pharm. Co., Ltd. Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same
SI2484346T1 (sl) 2006-06-19 2017-05-31 Alpharma Pharmaceuticals Llc Farmacevtski sestavki
CA2665726C (en) * 2006-10-11 2016-04-19 Alpharma, Inc. Pharmaceutical compositions
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
WO2009079521A1 (en) * 2007-12-17 2009-06-25 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
JP5819329B2 (ja) * 2010-03-09 2015-11-24 アルカーメス ファーマ アイルランド リミテッド アルコール耐性腸溶性医薬組成物
CA2936741C (en) 2014-10-31 2018-11-06 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1228757B (de) * 1962-06-28 1966-11-17 Haessle Ab Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen
JPS51127041A (en) * 1975-04-23 1976-11-05 Toyama Chem Co Ltd A process for preparing novel 2-( substituted phenyl) alkane acids and their salts.
US4447454A (en) * 1977-04-01 1984-05-08 The Upjohn Company Analgetic compounds, compositions and process of treatment
CA1125698A (en) * 1978-03-09 1982-06-15 Masaru Yoshida Process for preparing a polymer composition
JPS6028809B2 (ja) * 1979-08-21 1985-07-06 日本原子力研究所 イブプロフエン徐放剤組成物の製造方法
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
US4713249A (en) * 1981-11-12 1987-12-15 Schroeder Ulf Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DE3205504C2 (de) * 1982-02-16 1983-12-01 Dolorgiet Gmbh & Co Kg, 5300 Bonn Äußerlich anwendbares, Ibuprofen enthaltendes Arzneimittel
US4587249A (en) * 1982-07-22 1986-05-06 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
NL191432C (nl) * 1982-07-22 1995-07-04 Vicks Richardson Farmaceutisch preparaat omvattende naproxen en een andere werkzame verbinding.
GB2132887A (en) * 1982-11-15 1984-07-18 Procter & Gamble Enteric-coated anti-inflammatory compositions
JPS59122425A (ja) * 1982-12-27 1984-07-14 Kaken Pharmaceut Co Ltd 持続性製剤およびその製造法
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4684516A (en) * 1983-08-01 1987-08-04 Alra Laboratories, Inc. Sustained release tablets and method of making same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4522826A (en) * 1984-02-08 1985-06-11 Richardson-Vicks Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4585783A (en) * 1984-02-08 1986-04-29 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011132219A (ja) * 2009-11-24 2011-07-07 Taisho Pharmaceutical Co Ltd イブプロフェン含有固形製剤

Also Published As

Publication number Publication date
DK616186D0 (da) 1986-12-19
GR3002579T3 (en) 1993-01-25
DK616186A (da) 1987-12-26
DE3681031D1 (de) 1991-09-26
ATE66370T1 (de) 1991-09-15
CN86108644A (zh) 1988-01-06
ZA869586B (en) 1988-07-27
EP0250648A3 (en) 1988-03-23
US4867987A (en) 1989-09-19
NO173081C (no) 1993-10-27
FI88580B (fi) 1993-02-26
KR880000090A (ko) 1988-03-23
CA1276560C (en) 1990-11-20
KR930008956B1 (ko) 1993-09-17
EP0250648B1 (de) 1991-08-21
NO173081B (no) 1993-07-19
CH669523A5 (en, 2012) 1989-03-31
NO865195D0 (no) 1986-12-19
FI88580C (fi) 1993-06-10
EP0250648A2 (de) 1988-01-07
NZ218734A (en) 1990-03-27
AU6680786A (en) 1988-01-07
FI865227A7 (fi) 1987-12-26
FI865227A0 (fi) 1986-12-19
IL81045A0 (en) 1987-03-31
NO865195L (no) 1987-12-28
AU590370B2 (en) 1989-11-02
IL81045A (en) 1990-11-05
ES2029228T3 (es) 1992-08-01
CN1023191C (zh) 1993-12-22

Similar Documents

Publication Publication Date Title
JPS635020A (ja) 制御放出性イブプロフエン製剤
KR880001090B1 (ko) 디피리다몰의 경구용 제형의 제조방법
US5529783A (en) Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally dextromethorphan
JP2519296B2 (ja) イブプロフェン除放性錠剤及びその製造方法
JP4638964B2 (ja) プロトンポンプ阻害剤およびｎｓａｉｄからなる経口用医薬剤形
JP2720932B2 (ja) 経口投与用アセトアミノフエン錠剤の製造法及びアセトアミノフエン二層錠剤
EP0533297B1 (en) Controlled-release pharmaceutical formulations
KR100371523B1 (ko) 테오필린 서방성 정제
EP1112064B1 (fr) Procede de preparation de nouvelles formulations galeniques du fenofibrate, formulations galeniques obtenues par ledit procede et leurs applications
JPH0122245B2 (en, 2012)
JPH0753365A (ja) γ−ヒドロキシ酪酸塩による制御放出能をもつ薬化学組成物
JP2002087952A (ja) 味遮蔽製薬粒子
JP2003508430A (ja) トラマドールサッカリナートを含有する徐放性投薬形
JPH07558B2 (ja) モピダモール製剤
JP2001511156A (ja) 高いバイオアベイラビリティーを有するフェノフィブレート医薬組成物及びそれを調製するための方法
JPH11506433A (ja) 結腸送達のための多重腸溶性ポリマーコーティングを有するビサコジル投与形態
JP2003502359A (ja) 新規製剤
WO2009138642A1 (fr) Forme orale solide dotee d'un double profil de liberation comprenant des multiparticules
FR2819720A1 (fr) Nouveaux comprimes de fenofibrate
CN115297848B (zh) 一种非布司他片
WO2005053659A1 (en) An improved pharmaceutical formulation containing tamsulosin salt and a process for its preparation
JP2003510347A (ja) 抗炎症医薬品製剤
EP1465607A1 (fr) Compositions pharmaceutiques a liberation modifiee
JP2003523981A (ja) モルシドミンの放出時間延長を伴う経口投与用新規生薬製剤
JP2002179571A (ja) 小型徐放性錠剤